-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Downgrades Enlivex Therapeutics to Hold

Benzinga·11/24/2025 15:41:42
Listen to the news
D. Boral Capital analyst Jason Kolbert downgrades Enlivex Therapeutics (NASDAQ:ENLV) from Buy to Hold.